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Background: Obesity is a worldwide health problem with increasing prevalence. Decrease in energy intake has
been shown to lower the risk of coronary artery disease in obese subjects. The common form of dietary restriction
is daily calorie restriction (CR). Another form is alternate-day fasting (ADF). This study examined the ability of
modified ADF to facilitate weight loss and lower cardiovascular risk factors in overweight and obese women.
Methods: 15 adult subjects completed an 8 weeks trial (2 weeks observed and 6 weeks ADF). All women
consumed very low calorie diet on the fast day and usually diet in every other day. Body weight (BW), fat mass and
blood pressure (BP) were measured. Fasting blood samples were collected at the first and 57th day of trial for
biochemical analysis.
Results: During the course of the trial, BW of the subjects decreased (p < 0/0001) from 84/3 ± 11/44 kg to 78/3 ±
10/18 kg. Waist Circumference decreased from 87/87 ± 9/74 to 82/86 ± 9/68(p < 0/001). Reduction in systolic BP
was seen from 114.8 ± 9.16 to 105.13 ± 10.19 mmHg (p < 0/001) and diastolic BP changed from 82.86 ± 10.6 to
74.5 ± 10.8 (P < 0.05). Total cholesterol decreased from 227/73 ± 49/96 to 214/67 ± 43/27, TG from 160/5 ± 46/18
to 143/9 ± 22/77, LDL from 149/46 ± 49/81 to 131/3 ± 50/97, and FBS from 102 ± 14/7 to 96 ± 11/79 mg/dl but
were not significant. HDL increased from 42/32 ± 18/01 to 50/58 ± 19/46 and was not significant.
Conclusion: These finding suggest that short time ADF is a viable dietary option to help obese individuals lose
weight and decrease some CAD risk factors. More and longer-term studies in human subjects are needed to
support this important result.
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Obesity has become an important worldwide health
problem, with a rapidly increasing prevalence. The
World Health Organization has estimated that by 2015
approximately 2.3 billion adults will be overweight and
more than 700 million obese [1]. Obesity is associated
with an increased risk of diabetes, cardiovascular events,
stroke and cancer [2]. Moreover, a decrease in energy in-
take has been shown to lower the risk of Cardiovascular
Diseases (CVD) such as Coronary Artery Diseases in
obese populations [3]. The most common form of diet-
ary restriction implemented is daily calorie restriction* Correspondence: msoheila66@yahoo.com
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use, distribution, and reproduction in any med(CR), which requires individuals to decrease their energy
intake by 15 to 40% of baseline needs - while maintain-
ing adequate nutrient intake each day. Another form of
dietary restriction used, although far less commonly, is
alternate day fasting (ADF) [4]. The ability of modified
alternate day fasting [ADF; i.e., consuming 25% to 40%
of energy needs on the fast day and ad libitum food in-
take on the following day [5] to facilitate weight loss
and lower vascular disease risk in human subjects has
yet to be investigated. This form of dietary restriction
may be more feasible in practice than daily CR. The rela-
tion between ADF and cardio protection in human stud-
ies remains uncertain. Accordingly, the objective of the
present study was to examine the effects of modified
ADF diet on body weight, BMI, waist circumference,ee BioMed Central Ltd. This is an Open Access article distributed under the
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted
ium, provided the original work is properly cited.
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as systolic and diastolic BP, FBS, serum TG, LDL, HDL
and total cholesterol in obese women.
Material and methods
This study was approved by the research ethics commit-
tee of the Golestan University of Medical sciences,
Gorgan-Iran. A written consent form was signed by each
participant.
Subjects
Of the 30 overweight or obese women screened, 15 par-
ticipants completed a 8-wk trial, that includes 2 weeks
observed and 6 weeks ADF diet. Baseline characteristics
of the participants are shown in Table 1. Inclusion cri-
teria were age 20 – 45 y, BMI ≥ 25 kg/m2, normotensive
(<140/90 mm Hg), no weigh changes more and less than
10% for 3 months before the beginning of study, no his-
tory of cardiovascular, renal and metabolic disease; non-
smoker. None of the subjects was taking any medication
that is known to influence lipid, or glucose metabolism
in last 6 months. All women had regularly cycling with
menses appearing every 27–32 days. Pregnant women or
those trying to become pregnant were excluded. The
subjects had similar level of physical activity: less than
3 hours walking in week.
Diet protocol
During the baseline control period (for 2 weeks), each
subject was required to keep their body weight stable by
maintaining their usual eating and activity habits, then,
during 6-week ADF period, all subjects consumed very
low calorie diet (25 to 30% energy needs) on the 3 fast
day (Saturday, Monday, Wednesday) and then consumed
usual diet based on the “Key Recommendations of Diet-
ary Guidelines for Americans” [6] includes about 1700–
1800 Kcal/d in every other days (3 days a week). In
Friday subjects consume ad libitum without limitation. All
foods were prepared in the home and served in 3 meal
and 2 or 3 snacks. Energy free beverage (such as water,
tea, green tea, coffee without sugar), non starchy vegetable
(such as lettuce, cucumber, green leaf, tomato) and
sugar free gums were free. Daily dietary carbohydrate,Table 1 Baseline characteristics of the participants (n = 15)
Age (y) 33.46 ± 5.9
Weight (kg) 84.3 ± 11.44
BMI (kg/m2) 33.16 ± 5.02
Waist circumference 87.87 ± 9.74
Fat mass (%) 45.82 ± 4.16
Systolic blood pressure (mm Hg) 114.8 ± 9.16
Diastolic blood pressure (mm Hg) 82.86 ± 10.6
All values are presented as Mean ± SD.fat and protein accounted for 55, 25, and 20% of
ingested energy, respectively.
Measures
Body weight, BMI, waist circumference, blood pressure
and fat mass were measured in first visit and each 2 week
throughout period of trial. Body weight was measured
with a Seca Digital scale (Clara 803 - Germany) to the
nearest 0.1 kg in the evening of fast day, without shoes,
and in light clothing. BMI was assessed as the weight in
kilograms divided by the square of the height in meters.
Fat mass and fat-free mass were assessed using a tetra-
polar bioelectrical impedance analyzer (Omron HBF-
510). The instrument recorded impedance from hand to
foot and consequently, calculated fat mass and skeletal
muscle percentage from the impedance value and the
personal particulars (weight, height, age, and sex). Waist
circumference was measured in triplicate in standing
subjects at the midpoint between the lower margin of
the last palpable rib and the top of the iliac crest. Blood
pressure was measured with the Omron upper arm
blood pressure monitor in a seated position after a
10 minutes rest.
Twelve-hour fasting blood samples were collected (at
8.00 – 9.00 am) at the first day of ADF diet and after
6 weeks diet for biochemical analysis. Blood was centri-
fuged to separate plasma from RBCs, and was stored in
freeze (−70°C) until analyzed. Plasma total cholesterol,
HDL-C, and triacylglycerol concentrations were mea-
sured in duplicate using enzymatic kits, standardized
reagents, and standards (Pars Azmoon Co., Tehran,
Iran). LDL-C concentration was calculated using the
Friedewald equation [7].
Statistical analysis
Data were analyzed by using SPSS software (version 16).
Results are presented as means ± SEM. Compare be-
tween results before and after the trial were assessed by
paired T-test.
Results
15 participants completed an 8-wk trial. Baseline charac-
teristics of the participants are shown in Table 1.
During the baseline control period (2 wk) body weight of
the subjects was not changed. After the course of the
alternate-day fasting diet (6 wk), body weight decreased
(P < 0.0001) from mean 84.3 ± 11.44 kg to 78.3 ± 10.18
kg. Mean BMI of the subjects at baseline was 33.16 ±
5.02 kg/m2. At the end of the modified ADF course, BMI
decreased (P < 0.0001) to 30.72 ± 4.62 kg/m2, waist circum-
ference from 87.87 ± 9.74 cm to 82.86 ± 9.68 cm (P < 0.
001). Fat mass was significantly reduced from baseline in all
of the subjects. Systolic blood pressure decreased (P <
0.002) from 114.8 ± 9.16 mm Hg to 105.13 ± 10.19 mm Hg
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74.5 ± 10.8 mm Hg.
Changes in mean blood lipid and fasting blood sugar
concentrations were not significant after 6 weeks of
modified ADF. The anthropometric and biochemical
changes are presented in Table 2.
Discussion
This study shows that modified ADF is an effective, short
term dietary intervention to help obese individuals lose
weight and total body fat mass. Specifically, we show here
that an ADF regimen resulted in a mean 7.1% weight loss
of subjects from baseline after 6 wk of diet. Although CR
is often used to facilitate weight loss [8,9], many obese
patients find it difficult to continue because food intake
must be limited every day [10,11]. The ADF is a new strat-
egy that is capable for subject of self-selecting foods to
continue their individual feed and fast day energy goals
with the help of a dietitian for long time.
Our weight loss findings after 6 wk (6 ± 1.2 kg) are
comparable to those of Varady et al. (5.6 ± 1 kg) [4] and
Eshghinia et al. (4.7 ± 2.5 kg) findings [12]. Some re-
searcher reported less weight loss due to shorter time of
trial. Johnson et al. [13] were shown 4 kg weight loss
after 4 wk of ADF in overweight individuals.
According to these effects on body weight, ADF may
be considered a suitable alternative to CR to help obese
individuals lose weight in short period.
Waist circumference is associated with visceral obesity.
Elevated intra-abdominal fat area is associated with ele-
vated risk of coronary heart disease and type 2 diabetes
[14,15]. The ability of diet to reduce visceral fat mass
has a protective role against theses chronic diseases. In
our study, after 6 weeks of ADF diet, waist circumfer-
ence as the visceral fat mass was reduced by 5.7%
(p < 0.001) from baseline. In other studies visceral fatTable 2 Anthropometric and Biochemical indexes at
baseline and at the end of the trial
Index Before After P value
Weight (kg) 84.3 ± 11.44 78.3 ± 10.18 P < 0.001
BMI (kg/m2) 33.16 ± 5.02 30.72 ± 4.62 P < 0.001
Waist circumference 87.87 ± 9.74 82.86 ± 9.68 P < 0.001
Fat mass (%) 45.82 ± 4.16 42.98 ± 4.01 P < 0.001
Systolic blood pressure
(mm Hg)
114.8 ± 9.16 105.13 ± 10.19 P < 0.001
Diastolic blood pressure
(mm Hg)
82.86 ± 10.6 74.5 ± 10.8 P < 0.05
FBS (mg/dl) 102 ± 14.7 96 ± 11.79 NS
Total cholesterol (mg/dl) 227.73 ± 49.96 214.67 ± 43.27 NS
LDL cholesterol (mg/dl) 149.46 ± 49.81 131.3 ± 50.97 NS
HDL cholesterol (mg/dl) 42.33 ± 18.01 50.58 ± 19.46 NS
Triacylglycerols (mg/dl) 160.5 ± 46.18 143.9 ± 22.77 NS
P <0.05 is statistically significant.mass was reduced by 4–10% from baseline, that posi-
tively associated with body weight loss [4,12,16].
Body composition changes only reported in three of
the intermittent calorie restriction human trials with dif-
ferent methods [4,17,18]. In our study, percentage body
fat mass declined from 45.82 ± 4.16% at baseline to
42.98 ± 4.01% (p< 0.001) after 6 weeks. Varady et al. [4]
assessed fat mass with the same method (tetra-polar bio-
electrical impedance analyzer) and reported decreasing
of fat mass from 45 ± 1.6% to 42.1 ± 2% (P < 0.05) fol-
lowing 8 weeks ADF. Other trials had used dual-energy
X-ray absorptiometry [17,18].
The effects of 6 wk diet on blood pressure were also
assessed. Systolic and diastolic BP were lowered (p< 0.05)
by 9.7% and 8.3% respectively. Varady et al. [4] reported
5.1% reduce in systolic BP after 8 wk intervention, whereas
diastolic BP did not change. Eshghinia et al. findings sug-
gested decrease in systolic and diastolic BP following 4 wk
ADF intervention in mild to moderate hypertensive
women [12]. Results from another human study indicated
that after 3 wk of intervention, neither systolic nor dia-
stolic BP changed in subjects [16].
However, animal data indicate that ADF is effective in
decreasing fasting glucose and insulin concentrations,
Human trials have noted mixed findings with ADF
regarding glucoregulatory function [19]. In this study,
fasting glucose concentration decreased following
6 weeks ADF diet but was not statistically significant.
Eshghinia et al. found that fasting glucose significantly
reduces from baseline following 4 wk ADF in obese
women [12]. Heilbronn and colleagues [17] noted a de-
crease in fasting insulin but no difference in fasting glu-
cose after 22 days of ADF. In another study by the same
group [20] men on an ADF diet experienced a reduced
insulin response to the test meal, but this effect was not
observed in women. In addition, Halberg et al. [18]
found no change in fasting glucose or insulin concentra-
tions in men following a 14-day ADF trial. Taken to-
gether, these findings about blood glucose concentration
suggest that men and women may respond differently to
ADF. It seems that in future studies should examine
causes of the sex-specific differences noted above.
As a means of assessing cardiovascular response to
ADF, trials in this area have examined heart rate, blood
pressure, circulating lipids, and ischemic injury. In our
study serum TG, total cholestrol and LDL concentration
were lowered and HDL increased after 6 weeks. It is
possible; these effects resulted from the decreases in
body weight and fat mass. However these changes were
not statistically significant. Heilbron et al. [17] examined
the effect of ADF on CVD risk in both sex. When sub-
jects fasted on alternate days for 3 wk, circulating con-
centrations of HDL cholesterol increased in the women,
whereas triacylglycerol concentrations decreased in the
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differences.
Other study reported different result. Varady et al. [4]
showed 21.2%, 24.8% and 32% reduction in total choles-
terol, LDL and TG respectively but no changes in HDL
after 8 wk ADF program. In Eshghinia et al. findings,
fasting TG was not changed but total cholesterol, LDL
and HDL decreased (P < 0.01). This lack of benefit effect
of ADF on HDL cholesterol is not surprising because
this cardioprotective lipid parameter is generally increase
in response to exercise training [16,21].
It should be noted that this trial and many of other
ADF trials had not control groups, included limited sub-
jects and less than 8 weeks duration. A randomized con-
trolled trial with larger groups in longer time needs to
test these findings. The next step in the ADF field will
be to incorporate an exercise program into this diet to
test more benefits effects in lipid profile.
Conclusion
Our study was shown efficacy of 6 weeks ADF diet to
improve several key biomarkers of CAD risk, such as
obesity, waist circumference, fat mass, systolic and dia-
stolic blood pressure. The ADF method may be able to
modify serum lipid profile. These findings suggest that
ADF is a viable diet option to help obese individual loss
weight and decrease some CAD risk factors.
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